Skip to content

Patient-reported Outcome Measures After Post-anesthesia Care Unit Delirium

Influence of Post-anesthesia Care Unit Delirium After Radical Prostatectomy on Self-reported Cognitive Function and Health-related Quality of Life

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04168268
Enrollment
222
Registered
2019-11-19
Start date
2017-11-28
Completion date
2018-12-11
Last updated
2019-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Delirium, Neurocognitive Disorders

Brief summary

To assess self-reported cognitive function and health-related quality of life in patients with and without early postoperative delirium

Detailed description

Neurocognitive disorders including postoperative delirium are a serious complication after surgery and anesthesia in the elderly. Postoperative delirium is an acute-onset diffuse brain dysfunction that is characterized by a fluctuating course of confusion, disorganized thinking, inattention, irritability, disturbances of the circadian rhythm, and disorders of consciousness. Post-anesthesia care unit (PACU) delirium occurs immediately after emergence from anesthesia and affects up to 45% of patients after elective surgery. It is unclear, whether PACU delirium is associated with intermediated or long-term adverse outcomes including neurocognitive disorders or mortality. The aim of this prospective observational was to assess self-reported cognitive function and health-related quality of life in patients with and without PACU delirium three months after radical prostatectomy.

Interventions

None listed

Sponsors

Universitätsklinikum Hamburg-Eppendorf
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* elective radical prostatectomy * \>60 years * fluent in German

Exclusion criteria

* preexisting cognitive impairment * cerebrovascular disease

Design outcomes

Primary

MeasureTime frameDescription
Self-reported cognitive failuresthree monthsCognitive Failures Questionnaire

Secondary

MeasureTime frameDescription
Health-related quality of lifethree monthsShort Form Health Survey 36

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 19, 2026